{"id":"https://openalex.org/W1856666089","doi":"https://doi.org/10.1016/j.ejmech.2015.08.046","title":"Cyclic alpha-conotoxin peptidomimetic chimeras as potent GLP-1R agonists","display_name":"Cyclic alpha-conotoxin peptidomimetic chimeras as potent GLP-1R agonists","publication_year":2015,"publication_date":"2015-08-29","ids":{"openalex":"https://openalex.org/W1856666089","doi":"https://doi.org/10.1016/j.ejmech.2015.08.046","mag":"1856666089","pmid":"https://pubmed.ncbi.nlm.nih.gov/26352676"},"language":"en","primary_location":{"id":"doi:10.1016/j.ejmech.2015.08.046","doi":"https://doi.org/10.1016/j.ejmech.2015.08.046","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ejmech.2015.08.046","pdf_url":null,"source":{"id":"https://openalex.org/S4210169613","display_name":"European Journal of Medicinal Chemistry","issn_l":"0223-5234","issn":["0223-5234","1768-3254"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073108453","display_name":"Joakim E. Swedberg","orcid":"https://orcid.org/0000-0003-4243-8660","observed_orcids":["https://orcid.org/0000-0003-4243-8660"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I4405277047","display_name":"Institute for Molecular Bioscience","ror":"https://ror.org/018kjjj71","country_code":"AU","type":"facility","lineage":["https://openalex.org/I165143802","https://openalex.org/I4405277047"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Joakim E. Swedberg","raw_affiliation_strings":["Institute for Molecular Bioscience, The University of Queensland, Brisbane, 4072 QLD, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Molecular Bioscience, The University of Queensland, Brisbane, 4072 QLD, Australia","institution_ids":["https://openalex.org/I165143802","https://openalex.org/I4405277047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058339404","display_name":"Christina I. Schroeder","orcid":"https://orcid.org/0000-0002-6737-6374","observed_orcids":["https://orcid.org/0000-0002-6737-6374"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I4405277047","display_name":"Institute for Molecular Bioscience","ror":"https://ror.org/018kjjj71","country_code":"AU","type":"facility","lineage":["https://openalex.org/I165143802","https://openalex.org/I4405277047"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Christina I. Schroeder","raw_affiliation_strings":["Institute for Molecular Bioscience, The University of Queensland, Brisbane, 4072 QLD, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Molecular Bioscience, The University of Queensland, Brisbane, 4072 QLD, Australia","institution_ids":["https://openalex.org/I165143802","https://openalex.org/I4405277047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036840646","display_name":"Justin M. Mitchell","orcid":"https://orcid.org/0000-0001-8391-5959","observed_orcids":["https://orcid.org/0000-0001-8391-5959"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I4405277047","display_name":"Institute for Molecular Bioscience","ror":"https://ror.org/018kjjj71","country_code":"AU","type":"facility","lineage":["https://openalex.org/I165143802","https://openalex.org/I4405277047"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Justin M. Mitchell","raw_affiliation_strings":["Institute for Molecular Bioscience, The University of Queensland, Brisbane, 4072 QLD, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Molecular Bioscience, The University of Queensland, Brisbane, 4072 QLD, Australia","institution_ids":["https://openalex.org/I165143802","https://openalex.org/I4405277047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087029469","display_name":"Thomas Durek","orcid":"https://orcid.org/0000-0003-0686-227X","observed_orcids":["https://orcid.org/0000-0003-0686-227X"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I4405277047","display_name":"Institute for Molecular Bioscience","ror":"https://ror.org/018kjjj71","country_code":"AU","type":"facility","lineage":["https://openalex.org/I165143802","https://openalex.org/I4405277047"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Thomas Durek","raw_affiliation_strings":["Institute for Molecular Bioscience, The University of Queensland, Brisbane, 4072 QLD, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Molecular Bioscience, The University of Queensland, Brisbane, 4072 QLD, Australia","institution_ids":["https://openalex.org/I165143802","https://openalex.org/I4405277047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053439487","display_name":"David P. Fairlie","orcid":"https://orcid.org/0000-0002-7856-8566","observed_orcids":["https://orcid.org/0000-0002-7856-8566"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I4405277047","display_name":"Institute for Molecular Bioscience","ror":"https://ror.org/018kjjj71","country_code":"AU","type":"facility","lineage":["https://openalex.org/I165143802","https://openalex.org/I4405277047"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"David P. Fairlie","raw_affiliation_strings":["Institute for Molecular Bioscience, The University of Queensland, Brisbane, 4072 QLD, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Molecular Bioscience, The University of Queensland, Brisbane, 4072 QLD, Australia","institution_ids":["https://openalex.org/I165143802","https://openalex.org/I4405277047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005746956","display_name":"David J. Edmonds","orcid":"https://orcid.org/0000-0001-9234-8618","observed_orcids":["https://orcid.org/0000-0001-9234-8618"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David J. Edmonds","raw_affiliation_strings":["Worldwide Medicinal Chemistry, CVMED, Pfizer Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Worldwide Medicinal Chemistry, CVMED, Pfizer Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016609209","display_name":"David A. Griffith","orcid":"https://orcid.org/0000-0002-7592-2478","observed_orcids":["https://orcid.org/0000-0002-7592-2478"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David A. Griffith","raw_affiliation_strings":["Worldwide Medicinal Chemistry, CVMED, Pfizer Inc., Cambridge, MA, USA"],"raw_orcid":"https://orcid.org/0000-0002-7592-2478","affiliations":[{"raw_affiliation_string":"Worldwide Medicinal Chemistry, CVMED, Pfizer Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006534037","display_name":"Roger B. Ruggeri","orcid":"https://orcid.org/0000-0001-9813-1882","observed_orcids":["https://orcid.org/0000-0001-9813-1882"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roger B. Ruggeri","raw_affiliation_strings":["Worldwide Medicinal Chemistry, CVMED, Pfizer Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Worldwide Medicinal Chemistry, CVMED, Pfizer Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057508297","display_name":"David R. Derksen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David R. Derksen","raw_affiliation_strings":["Pharmacokinetics, Dynamics and Metabolism, Worldwide Research & Development, Pfizer Inc., Groton, CT, USA","Pharmacokinetics, Dynamics and Metabolism, Worldwide Research and Development, Pfizer Inc, Groton, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacokinetics, Dynamics and Metabolism, Worldwide Research & Development, Pfizer Inc., Groton, CT, USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Pharmacokinetics, Dynamics and Metabolism, Worldwide Research and Development, Pfizer Inc, Groton, CT, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011949689","display_name":"Paula M. Loria","orcid":"https://orcid.org/0000-0003-4690-5991","observed_orcids":["https://orcid.org/0000-0003-4690-5991"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paula M. Loria","raw_affiliation_strings":["Pharmacokinetics, Dynamics and Metabolism, Worldwide Research & Development, Pfizer Inc., Groton, CT, USA","Pharmacokinetics, Dynamics and Metabolism, Worldwide Research and Development, Pfizer Inc, Groton, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacokinetics, Dynamics and Metabolism, Worldwide Research & Development, Pfizer Inc., Groton, CT, USA","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Pharmacokinetics, Dynamics and Metabolism, Worldwide Research and Development, Pfizer Inc, Groton, CT, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072802372","display_name":"Spiros I. Liras","orcid":"https://orcid.org/0000-0002-0334-2095","observed_orcids":["https://orcid.org/0000-0002-0334-2095"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Spiros Liras","raw_affiliation_strings":["Worldwide Medicinal Chemistry, CVMED, Pfizer Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Worldwide Medicinal Chemistry, CVMED, Pfizer Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100694594","display_name":"David A. Price","orcid":"https://orcid.org/0000-0002-0862-2897","observed_orcids":["https://orcid.org/0000-0002-0862-2897"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David A. Price","raw_affiliation_strings":["Worldwide Medicinal Chemistry, CVMED, Pfizer Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Worldwide Medicinal Chemistry, CVMED, Pfizer Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079308758","display_name":"David J. Craik","orcid":"https://orcid.org/0000-0003-0007-6796","observed_orcids":["https://orcid.org/0000-0003-0007-6796"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I4405277047","display_name":"Institute for Molecular Bioscience","ror":"https://ror.org/018kjjj71","country_code":"AU","type":"facility","lineage":["https://openalex.org/I165143802","https://openalex.org/I4405277047"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"David J. Craik","raw_affiliation_strings":["Institute for Molecular Bioscience, The University of Queensland, Brisbane, 4072 QLD, Australia. Electronic address: d.craik@imb.uq.edu.au","Institute for Molecular Bioscience, The University of Queensland, Brisbane 4072 QLD, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Molecular Bioscience, The University of Queensland, Brisbane, 4072 QLD, Australia. Electronic address: d.craik@imb.uq.edu.au","institution_ids":["https://openalex.org/I165143802","https://openalex.org/I4405277047"]},{"raw_affiliation_string":"Institute for Molecular Bioscience, The University of Queensland, Brisbane 4072 QLD, Australia","institution_ids":["https://openalex.org/I165143802","https://openalex.org/I4405277047"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5079308758"],"corresponding_institution_ids":["https://openalex.org/I165143802","https://openalex.org/I4405277047"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":1.0124,"has_fulltext":false,"cited_by_count":26,"citation_normalized_percentile":{"value":0.74146851,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"103","issue":null,"first_page":"175","last_page":"184"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.6161999702453613,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.6161999702453613,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.2551000118255615,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.015200000256299973,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alpha-conotoxins","display_name":"alpha-conotoxins","score":0.8870000243186951},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9409999847412109},{"id":"https://openalex.org/keywords/peptidomimetics","display_name":"peptidomimetics","score":0.8939999938011169},{"id":"https://openalex.org/keywords/cyclic-peptides","display_name":"cyclic peptides","score":0.7770000100135803},{"id":"https://openalex.org/keywords/disulfide-bonds","display_name":"disulfide bonds","score":0.781000018119812},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.7620000243186951},{"id":"https://openalex.org/keywords/glp-1-analogues","display_name":"GLP-1 analogues","score":0.8920000195503235},{"id":"https://openalex.org/keywords/camp-signaling","display_name":"cAMP signaling","score":0.7059999704360962},{"id":"https://openalex.org/keywords/octanol-water-partition-coefficient","display_name":"octanol-water partition coefficient","score":0.8339999914169312},{"id":"https://openalex.org/keywords/radius-of-gyration","display_name":"radius of gyration","score":0.8690000176429749},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.656000018119812}],"concepts":[{"id":"https://openalex.org/C124790011","wikidata":"https://www.wikidata.org/wiki/Q2069797","display_name":"Peptidomimetic","level":3,"score":0.9241726994514465},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8405501246452332},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.4576614499092102},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.430730938911438},{"id":"https://openalex.org/C2778881409","wikidata":"https://www.wikidata.org/wiki/Q1420402","display_name":"Incretin","level":4,"score":0.4138849675655365},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.26700612902641296},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.08488312363624573},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.0787818431854248},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.06818273663520813},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000067757","descriptor_name":"Glucagon-Like Peptide-1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000097789","descriptor_name":"Glucagon-Like Peptide-1 Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003412","descriptor_name":"Cricetulus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016466","descriptor_name":"CHO Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020916","descriptor_name":"Conotoxins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D020916","descriptor_name":"Conotoxins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D057786","descriptor_name":"Peptidomimetics","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D057786","descriptor_name":"Peptidomimetics","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.ejmech.2015.08.046","doi":"https://doi.org/10.1016/j.ejmech.2015.08.046","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ejmech.2015.08.046","pdf_url":null,"source":{"id":"https://openalex.org/S4210169613","display_name":"European Journal of Medicinal Chemistry","issn_l":"0223-5234","issn":["0223-5234","1768-3254"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:26352676","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26352676","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8999999761581421,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Clean water and sanitation","score":0.5400000214576721,"id":"https://metadata.un.org/sdg/6"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G8441439601","display_name":"Design and evaluation of inhibitors targeting serine proteases in blood to alleviate systemic inflammatory response to coronary artery bypass graft surgery","funder_award_id":"1069819","funder_id":"https://openalex.org/F4320334705","funder_display_name":"National Health and Medical Research Council"}],"funders":[{"id":"https://openalex.org/F4320321995","display_name":"Queensland Government","ror":"https://ror.org/037405308"},{"id":"https://openalex.org/F4320334704","display_name":"Australian Research Council","ror":"https://ror.org/05mmh0f86"},{"id":"https://openalex.org/F4320334705","display_name":"National Health and Medical Research Council","ror":"https://ror.org/011kf5r70"},{"id":"https://openalex.org/F4320334737","display_name":"National Medical Research Council","ror":"https://ror.org/04x3cxs03"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":55,"referenced_works":["https://openalex.org/W115472378","https://openalex.org/W201400539","https://openalex.org/W1507814807","https://openalex.org/W1514410406","https://openalex.org/W1523913993","https://openalex.org/W1964072600","https://openalex.org/W1964673525","https://openalex.org/W1969932276","https://openalex.org/W1985110387","https://openalex.org/W1989850958","https://openalex.org/W1992986386","https://openalex.org/W2003589032","https://openalex.org/W2005331943","https://openalex.org/W2013778911","https://openalex.org/W2014014787","https://openalex.org/W2016542902","https://openalex.org/W2018274594","https://openalex.org/W2022101780","https://openalex.org/W2024726230","https://openalex.org/W2026018179","https://openalex.org/W2027100835","https://openalex.org/W2044342670","https://openalex.org/W2045275149","https://openalex.org/W2049502419","https://openalex.org/W2052390538","https://openalex.org/W2052876027","https://openalex.org/W2059183805","https://openalex.org/W2062292120","https://openalex.org/W2070753604","https://openalex.org/W2074078250","https://openalex.org/W2081293118","https://openalex.org/W2084948079","https://openalex.org/W2085405019","https://openalex.org/W2086759452","https://openalex.org/W2099099776","https://openalex.org/W2118384592","https://openalex.org/W2119255830","https://openalex.org/W2120890050","https://openalex.org/W2123127609","https://openalex.org/W2125053565","https://openalex.org/W2130189158","https://openalex.org/W2132629607","https://openalex.org/W2132802847","https://openalex.org/W2134293572","https://openalex.org/W2139532113","https://openalex.org/W2145824107","https://openalex.org/W2148103576","https://openalex.org/W2148889367","https://openalex.org/W2150981663","https://openalex.org/W2153342269","https://openalex.org/W2153399820","https://openalex.org/W2162291204","https://openalex.org/W2171109114","https://openalex.org/W2256731631","https://openalex.org/W2315889211"],"related_works":["https://openalex.org/W2741400332","https://openalex.org/W2980009427","https://openalex.org/W2014014787","https://openalex.org/W7160828268","https://openalex.org/W4280502247","https://openalex.org/W7042915912","https://openalex.org/W2044865569","https://openalex.org/W2917471675","https://openalex.org/W2910734677","https://openalex.org/W2519031788"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":5},{"year":2018,"cited_by_count":6},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}